Literature DB >> 11534319

[Therapy of myasthenia gravis].

G Rilling1, B Tettenborn.   

Abstract

The treatment of myasthenia gravis is a difficult entity. We especially discuss the immunosuppressive treatment with regard to the literature. In patients with thymoma all authors agree in thymectomy. In generalized myasthenia, even without thymoma, thymectomy should be performed in "younger" patients. In "elderly" patients thymectomy as treatment of choice is controversial. The basis of immunsuppressive therapy are corticosteroids, additionally azathioprine can be given considering the delay in response and the major side effects. As today, cyclophosphamide and cyclosporine A are too toxic for routine use, except third choice in therapy resistant patients as ultima ratio. The procedure of choice in myasthenic crisis is plasma exchange if the patient tolerates it. Alternatively intravenous immunoglobulin should be given. In pure ocular myasthenia treatment is controversial in the literature. In the last few years there is a tendency to treat this form early like generalized myasthenia, especially in young patients, to prevent generalization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534319

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  1 in total

1.  Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients.

Authors:  Kai Bachmann; Doreen Burkhardt; Inken Schreiter; Jussuf Kaifi; Christoph Busch; Gunther Thayssen; Jakob R Izbicki; Tim Strate
Journal:  Surg Endosc       Date:  2008-02-23       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.